Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04764734Not ApplicableUnknown

A Validation Study of the NightOwl Home Sleep Apnea Test

Role: lead

NCT04191668Not ApplicableCompleted

A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test

Role: lead

NCT04194073Not ApplicableUnknown

NightOwl SpO2 Calibration Study

Role: lead

NCT03385187Not ApplicableUnknown

Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test

Role: lead

NCT03774199Not ApplicableUnknown

NightOwl Pulse Oximeter Calibration Study

Role: lead

NCT03635918Not ApplicableUnknown

Extensive Prospective Validation Study of the NightOwl Home Sleep Apnea Test

Role: lead

All 6 trials loaded